|

Setidegrasib Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: ASP3082

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Astellas Pharma Inc1
  • Astellas Pharma Global Development, Inc.1

Indications

  • Cancer2
  • Metastatic Pancreatic Adenocarcinoma1
  • Metastatic Pancreatic Cancer1
  • Pancreatic Cancer1
  • Solid Tumor1

Duarte, California1 trial

A Study of ASP3082 in Adults With Advanced Solid Tumors

City of Hope National Medical Center

Phase 1

Fullerton, California1 trial

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.